Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-11-06

FDA Approved: RIOMET — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved a Sun Pharmaceutical supplemental application for RIOMET (metformin hydrochloride), updating the product's regulatory status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RIOMET (Metformin hydrochloride)

Snippet

SUPPL AP for RIOMET (METFORMIN HYDROCHLORIDE)